DB-1303/BNT323 Evidence: Trial Results and Peer-Reviewed Publications
Hipa.ai Research · Source: PubMed & ClinicalTrials.gov / AACT · Last updated:
The clinical evidence base for DB-1303/BNT323 comprises 1 peer-reviewed publications across 1 journals, 0 pivotal-trial primary-outcome rows reported to ClinicalTrials.gov, spanning indications including Endometrial Neoplasms. Most recent publication: Molecular Characterization and Clinical Implications of Endometrial Cancer., Obstet Gynecol, 2025.
Top peer-reviewed publications
Curated set of pivotal-trial result papers and recent publications in high-tier journals.
- Molecular Characterization and Clinical Implications of Endometrial Cancer.Secord AA, Powell MA, McAlpine J, et al. · Obstet Gynecol · 2025
Publications by year
2025–2025: 1 publications.
2025
1
Publications by indication
Endometrial Neoplasms (1)
- Molecular Characterization and Clinical Implications of Endometrial Cancer.
Publications by journal
- Obstet Gynecol1 paper
All DB-1303/BNT323 publications (1)
2025 (1 paper)
- Molecular Characterization and Clinical Implications of Endometrial Cancer.Secord AA, Powell MA, McAlpine J, et al. · Obstet Gynecol · 2025 · Derived
Sources and methodology
- Publications:
ctgov.study_references(PubMed PMIDs auto-attached by ClinicalTrials.gov to each trial), reference typesRESULT,DERIVED, andBACKGROUND. - Per-arm outcome values:
ctgov.outcome_measurementsjoined toctgov.design_outcomeswhereoutcome_type = 'PRIMARY', restricted to phasePHASE3andPHASE2/PHASE3. - Publication metadata (title, journal, year, authors): PubMed E-utilities
efetch.fcgi - Data freshness: Tue, 26 May 2026 18:13:19 GMT.
This page summarizes published evidence for general reference and does not constitute medical advice. For clinical decisions, consult the linked primary publications and your healthcare provider. Data sourced from PubMed and the ClinicalTrials.gov / AACT database maintained by the Clinical Trials Transformation Initiative (CTTI).